Open AccessDiagnosis and Treatment of Juvenile Nasopharyngeal Angiofibroma: Impressions from a University Hospital
Author(s) -
Barros Bruno B. C.,
Prata Anelise A. S.,
Macoto Eduardo M.,
Fonseca Viviane M. G.
Publication year - 2011
Publication title -
otolaryngology–head and neck surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.232
H-Index - 121
eISSN - 1097-6817
pISSN - 0194-5998
DOI - 10.1177/0194599811415823a337
Subject(s) - medicine , juvenile nasopharyngeal angiofibroma , endoscope , embolization , surgery , medical record , retrospective cohort study , blood transfusion , angiofibroma
Objective Describe the characteristics of diagnosis and treatment of JNA at a teaching hospital. Method A retrospective cross‐sectional study was conducted by revision of medical records from patients treated for juvenile nasopharyngeal angiofibroma between January 2007 and October 2010. Results There were 11 patients, all males, with mean age of 15.18 years, who underwent surgery. Nasal obstruction was the initial symptom (54.55%), followed by epistaxis (45.45%). Stage II of Andrews was most commonly observed (54.55%). Preoperative embolization was performed in 45.45% of patients, and the most common approach was endoscopic‐assisted mid‐facial degloving (72.73%). Intraoperative blood transfusion was necessary in 72.73%, due to decrease in hemoglobin average from 13.18 to 8.54 g/dL. ICU hospitalization average was 2.78 days, and hospital discharge average was 8.18 days. Recurrence occurred in 2 cases, totaling 18.18% of failure. Preoperative embolization and use of endoscope reduced risk of relapser=0.77 (Pearson correlation). Conclusion We described our experience and found that preoperative embolization and use of endoscope reduced risk of relapse.